Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

6.8%

3 terminated out of 44 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

11%

5 trials in Phase 3/4

Results Transparency

43%

9 of 21 completed with results

Key Signals

9 with results88% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (24)
P 1 (3)
P 2 (2)
P 3 (3)
P 4 (2)

Trial Status

Completed21
Not Yet Recruiting6
Recruiting6
Active Not Recruiting4
Terminated3
Enrolling By Invitation2

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT07039539Not ApplicableNot Yet Recruiting

Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial

NCT07001020Not ApplicableCompleted

Innovating Technology Solutions for Residents in Support Housing Communities w SUD Through Community-Engaged Research

NCT07631559Not ApplicableNot Yet Recruiting

Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs

NCT06429436Phase 4Active Not RecruitingPrimary

Vending Machine Naloxone Distribution for Your Community (VENDY)

NCT06187415Not ApplicableCompletedPrimary

Harm Reduction Strategies for Gay, Bisexual and Other Men Who Have Sex With Men Engaging in Chemsex

NCT05463341Not ApplicableActive Not Recruiting

Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties

NCT06271668Active Not Recruiting

Clinical Decision Support to Improve System Naloxone Co-prescribing

NCT06526286Not Yet Recruiting

Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder

NCT06527079Not Yet Recruiting

Evaluation of Clinical Decision Support in Opioid Tapering

NCT06527040Not Yet Recruiting

Clinical Decision Support for Safety of Opioid Transitions

NCT07274475Not ApplicableNot Yet Recruiting

Smoking Harm Reduction Using E-cigarettes and Cytisine

NCT06372899Not ApplicableRecruiting

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

NCT06215664Not ApplicableTerminated

Game-Based Intervention to Reduce Alcohol-Related Harms Among Sexual and Gender Minority Youth

NCT06843213Not ApplicableRecruiting

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

NCT06554873Phase 3Completed

Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders

NCT05493475Not ApplicableCompleted

Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

NCT05994703Phase 2Completed

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

NCT07157540Not ApplicableEnrolling By Invitation

Testing the Effects of Cann'App, a Digital Intervention for Cannabis Harm Reduction

NCT04351958Not ApplicableEnrolling By Invitation

An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens

NCT06115746Not ApplicableRecruiting

A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

Scroll to load more

Research Network

Activity Timeline